Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

GRAND TRAVERSE BAND, LLC

Parent1 subsidiaryUEI: M9DFAHL7LGG1CAGE: 87XJ8

GRAND TRAVERSE BAND, LLC is a federal contractor, registered under UEI M9DFAHL7LGG1 and CAGE code 87XJ8. It has been awarded $1,319,168 across 422 federal contracts. Primary work spans Unknown NAICS. Top awarding agencies include Department Of Health And Human Services.

Contact Information

Registration and classification details

Registration

UEI Code

M9DFAHL7LGG1

CAGE Code

87XJ8

Entity Structure

Other

Established

N/A

Business Classifications

1B23272XLJNBOWXY

NAICS Codes

551112Offices of Other Holding Companies(Primary)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

GRAND TRAVERSE BAND, LLC operates as a government contractor under the NAICS code 551112, which corresponds to management of companies and enterprises. This classification indicates the firm provides high-level administrative, strategic, and operational oversight services, typically supporting compl...

GRAND TRAVERSE BAND, LLC operates as a government contractor under the NAICS code 551112, which corresponds to management of companies and enterprises. This classification indicates the firm provides high-level administrative, strategic, and operational oversight services, typically supporting complex organizational structures through executive management, financial planning, governance, and corporate policy development. The company’s technical expertise centers on institutional governance, resource allocation, and enterprise-level coordination, enabling efficient delivery of mission-critical functions for public sector clients. Its specialization lies in managing multi-faceted operations with an emphasis on compliance, accountability, and long-term strategic alignment, particularly within federally funded programs requiring structured governance frameworks. Award history is not available to determine specific agency relationships or project types, so no direct experience with federal departments or agencies can be confirmed. Similarly, without contract data, it is not possible to identify vertical specializations or recurring service lines beyond the broad scope implied by the primary NAICS code. The firm is structured as a ZZ entity, indicating it is a non-profit organization, likely affiliated with a federally recognized tribe, given its name and location in Traverse City, Michigan. It holds no formal government certifications such as 8(a), HUBZone, or WOSB. Its geographic presence is localized to Michigan, with no indication of nationwide operations. Market positioning is defined by its unique tribal governance structure and capacity to serve as a steward of federally entrusted resources, though without contract performance data, its role in the federal contracting ecosystem remains broadly defined by its corporate classification rather than demonstrated project execution.

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Award Analytics & Distribution

Awards by Agency
Department Of Health And Human Services$1.3M100%
Awards by NAICS
- Unknown NAICS$1.3M100%
Awards by Agency Over Time
Awards by Place of Performance

Compete with GRAND TRAVERSE BAND, LLC

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for GRAND TRAVERSE BAND, LLC

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS

Open opportunities in GRAND TRAVERSE BAND, LLC's top NAICS codes and agencies

NAICS: 541715
SBIR / STTR
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
Solicitation # PA-27-102
The National Institutes of Health (NIH) funding opportunity PA-27-102 supports U.S. small business concerns (SBCs) in performing research and development to create commercial products that enhance health, lengthen life, and reduce illness and disability. A mandatory requirement for this Small Business Technology Transfer (STTR) program is a formal collaboration with a non-profit research institution. The program is structured in phases, with Phase I focusing on establishing technical merit and feasibility, and Phase II advancing the research toward commercialization. Eligible applicants include for-profit entities located in the U.S. with no more than 500 employees, which must be more than 50 percent owned and controlled by U.S. citizens or permanent resident aliens. The opportunity accepts Phase I, Phase II, Direct to Phase II, and Fast-Track applications, with budget limits varying by institute, typically ranging from 400,000 to 700,000 dollars for Phase I and up to 3,000,000 dollars for Phase II. Applications are evaluated based on scientific and technical merit through a peer review system, resulting in an overall impact score. Key evaluation criteria include commercial potential, the quality of the commercialization plan, and, for clinical trials, the scientific rationale and regulatory plan. While clinical trials are generally permitted, they are not accepted by specific components such as NIAID, NIAMS, NIDCR, NIDDK, NIMHD, NCATS, and ORIP. Recipients must adhere to strict administrative requirements, including maintaining active SAM and UEI registrations, implementing cybersecurity incident reporting procedures with a 48-hour notification window, and registering applicable clinical trials on ClinicalTrials.gov. Submissions must be made via Grants.gov and tracked through eRA Commons, with a response deadline of April 6, 2027.
Department of Health and Human Services

POSTED

4 months ago

DEADLINE

in 7 months
View Details
NAICS: 541715
SBIR / STTR
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
Solicitation # PA-27-100
The NIH, CDC, and FDA Small Business Innovation Research (SBIR) grant, solicitation PA-27-100, provides early-stage funding to United States small business concerns (SBCs) to conduct research and development for commercial products that support the missions of these agencies. The program is structured in phases, with Phase I focusing on establishing technical merit and feasibility and Phase II advancing the research toward commercialization. Eligible applicants include for-profit U.S. businesses with fewer than 500 employees. The opportunity accepts Phase I, Phase II, Direct to Phase II, and Fast-Track applications. Funding levels vary by participating institute, with Phase I awards typically ranging from 400,000 to 700,000 dollars and Phase II awards reaching up to 3,000,000 dollars. Awards are based on scientific and technical merit, fund availability, and relevance to program goals, with a heavy emphasis on significance, environment, and commercial potential. While clinical trials are generally permitted, certain institutes, including the FDA components and NCATS, do not accept them under this specific notice. Applicants must maintain active SAM registration and a Unique Entity Identifier. Special requirements include a 48-hour cybersecurity incident reporting window and mandatory registration of applicable clinical trials on ClinicalTrials.gov. Applications must be submitted electronically via ASSIST, Grants.gov Workspace, or an institutional system-to-system solution by the deadline of April 6, 2027.
Department of Health and Human Services

POSTED

4 months ago

DEADLINE

in 7 months
View Details
NAICS: 541715
SBIR / STTR
SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)
Solicitation # PAR-27-098
The Commercialization Readiness Pilot (CRP) program, under solicitation PAR-27-098, provides later-stage research and development and technical assistance to small business concerns that have previously received an NIH SBIR or STTR Phase II or Phase IIB Strategic Breakthrough award. The program is designed to bridge the gap between late-stage development and full commercialization by supporting activities such as clinical trials, IND or IDE-enabling studies, manufacturing scale-up, regulatory strategy, and intellectual property planning. While significant outsourcing to contract research organizations is permitted, the small business must maintain a substantial role in the oversight and management of the project. The maximum project period is three years, and funding levels vary by NIH institute, ranging from 500,000 to 2,000,000 dollars. Eligible applicants must maintain active registrations in the System for Award Management and the SBA Company Registry. Applications are evaluated based on scientific and technical merit through a peer review system, with a focus on the project's likelihood to exert a powerful influence on the relevant market. Certain NIH components, including the NHLBI, NIAID, and NCATS, among others, do not accept clinical trials under this specific funding opportunity. Prohibited costs include patent or FDA filing fees and separate Technical and Business Assistance funding. All applications must be submitted electronically by the specified deadlines, with the program expiring on April 6, 2029.
Department of Health and Human Services

POSTED

4 months ago

DEADLINE

in 7 months
View Details